
June 1, 2016 Medical Communications, Research and Development, Sales and Marketing Biogen, CHMP, EMA, Tysabri, multiple sclerosis

June 1, 2016 Medical Communications, Research and Development Huntington disease, Teva, US FDA, regulation

May 27, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

May 27, 2016 Medical Communications, Research and Development EMA, Guidelines, amend, clinical trial, review, revise

May 27, 2016 Medical Communications, Research and Development, Sales and Marketing CHMP, EMA, Revestive, Shire, gastrointestinal, paediatric, short bowel syndrome, treatment

May 27, 2016 Medical Communications, Research and Development Comparison Study, Roche, drug trial, follicular lymphoma
May 27, 2016 Medical Communications, Research and Development AstraZeneca, NDA, US FDA, regulation
May 27, 2016 Medical Communications, Sales and Marketing FDA, addiction, buprenorphine, dependence, implant, opioid, probuphine

May 27, 2016 Medical Communications, Research and Development, Sales and Marketing AstraZeneca, breast cancer, comparision study, drug trial

May 25, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medivation, Sanofi, removal of board, takeover

May 25, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead
May 24, 2016 Medical Communications, Sales and Marketing NHS, commissioning

May 23, 2016 Medical Communications, Sales and Marketing US department of agriculture, animal cruelty, animal mistreatment, antibody, santa cruz biotechnology, usda

May 20, 2016 Medical Communications Central African republic, MSF

May 20, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, actimmune, agreement, horizon, interferon gamma-1b, worldwide rights